دورية أكاديمية

Comparison of the Impact of Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Dual Combination Therapy and Immune Checkpoint Inhibitor Plus Tyrosine Kinase Inhibitor Combination Therapy in Patients with Advanced Renal Cell Carcinoma

التفاصيل البيبلوغرافية
العنوان: Comparison of the Impact of Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Dual Combination Therapy and Immune Checkpoint Inhibitor Plus Tyrosine Kinase Inhibitor Combination Therapy in Patients with Advanced Renal Cell Carcinoma
المؤلفون: Ishihara, HirokiAff1, Aff2, IDs11523022009408_cor1, Nemoto, YukiAff1, Aff2, Nakamura, KazutakaAff2, Aff3, Tachibana, Hidekazu, Fukuda, Hironori, Yoshida, Kazuhiko, Kobayashi, Hirohito, Iizuka, Junpei, Shimmura, Hiroaki, Hashimoto, Yasunobu, Kondo, Tsunenori, Takagi, Toshio
المصدر: Targeted Oncology. 18(1):159-168
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:17762596
1776260X
DOI:10.1007/s11523-022-00940-8